Shri Ahimsa Naturals

Shri Ahimsa Naturals Limited - IPO

SME

Shri Ahimsa Naturals Stock Price

150.00 A2ZIPO
-2.20 (-1.45%)
12 Jun, 2025 02:47:29 PM | All Prices in ₹
Previous Close
152.20
Open
154.00
High
154.00
Low
150.00
Exchange
NSE
52 week High (24 Apr 2025)
173.00
52 week Low (09 Apr 2025)
126.50
Upper Price Band
182.60
Lower Price Band
121.80
Price Band
20.00%
All Prices in ₹
Previous Close
-
Open
-
High
-
Low
-
Exchange
BSE
52 week High
-
52 week Low
-
Upper Price Band
-
Lower Price Band
-
Price Band
-

Shri Ahimsa Naturals IPO Details

Open Date
25 Mar 2025
Close Date
27 Mar 2025
Listing Date
02 Apr 2025
Issue Price
₹113 - ₹119
Face Value
₹10 per share
Lot Size
1200
GMP
₹19 (16.0%)
Issue Type
IPO
Listing On
NSE
Type
Book Built Issue
Share holding pre issue
19126500
Share holding post issue
23330100
Total Issue Size
62,02,800 shares (aggregating up to ₹73.81 Cr)
Fresh Issue
42,03,600 shares (aggregating up to ₹50.02 Cr)
Offer for Sale
19,99,200 shares (aggregating up to ₹23.79 Cr)

Shri Ahimsa Naturals IPO Subscription

Shri Ahimsa Naturals IPO Application Wise Breakup

Shri Ahimsa Naturals IPO Dates

  • 25 Mar 2025
    Opening dateOPD
  • 27 Mar 2025
    Closing dateCOD
  • 28 Mar 2025
    Basis of AllotmentBOA
  • 01 Apr 2025
    Initiation of RefundsIOR
  • 01 Apr 2025
    Credit of SharesCOS
  • 02 Apr 2025
    Listing dateLID

Shri Ahimsa Naturals IPO Lot Size

ApplicationLotsSharesAmount
Retain Minimum11200₹142,800
Retain Maximum11200₹142,800
HNI Minimum22400₹285,600

Shri Ahimsa Naturals IPO Reservation

Promoter Holding

Pre Issue:94.22%
Post Issue:68.68 %
Promoter Names:
Mr Nemi Chand Jain, Mrs Sumitra Jain, Mr Amit Kumar Jain, Mr Sumit Jain, Mrs Prerna Jain, M/s Ahimsa Holdings Private Limited, M/s Bimneer Investments Private Limited

Shri Ahimsa Naturals IPO Valuations

ROE:22.25%
ROCE:25.69%
DEBT/EQUITY:0.07
RONW:22.25%

Shri Ahimsa Naturals Limited Financial Information

Period Ended30 Sep 202431 Mar 202431 Mar 202331 Mar 2022
Assets111.39103.1574.1340.34
Revenue41.3778.7106.1458.94
Profit After Tax9.7418.6738.2111.02
Net Worth99.6783.8965.2227.02
Reserves and Surplus80.5465.5759.9921.78
Total Borrowing4.8513.833.436.36
Amount in ₹ Crore

About Shri Ahimsa Naturals IPO

Incorporated in 1990, Shri Ahimsa Naturals Limited extracts and manufactures Caffeine Anhydrous, Green Coffee Bean Extracts, and Crude Caffeine, also trading other herbal extracts.

The company's products find its application in the food & beverage, nutraceuticals, cosmetics and pharmaceutical industries due to their health benefits.

The company's product portfolio includes the following:-

Natural Caffeine:Extracted from seeds of various plants like coffee and tea, their caffeine is used in energy drinks, soft drinks, cosmetics, and pharmaceuticals.

Green Coffee Bean Extract:Sourced from unroasted green coffee seeds, this extract is rich in chlorogenic acid, known for its antioxidant properties and potential weight loss benefits.

The company exports its products to the USA, Germany, South Korea, the UK, Thailand, etc.

For the period ending September 30, 2024, revenue from exports (including deemed exports) of the Company’s products was ₹3,530.91 lakhs, ₹7,463.71 lakhs, and ₹9,988.01 lakhs for Fiscal 2023 and ₹5,633.50 lakhs for Fiscal 2022.

The manufacturing unit is situated in Jaipur, Rajasthan.

The manufacturing facility complies with 2015 [Quality Management System], 2018 ISO 22000 [Food Safety Management System], 2018 ISO 45001 [Occupational Health & Safety Management System], 2015 ISO 14001 [Environmental Management System], HACCP, and GMP guidelines for superior quality.

As of March 2025, the company employed about 80 employees.

Strength Of Shri Ahimsa Naturals IPO

1. Experienced Promoters and Management Team.

2. Manufacturing facility supported by technology driven process and R&D capabilities.

3. Quality Service.

4. Long term relationship with the clients.

5. Healthy relationship with Crude Caffeine Suppliers.

Risk Of Shri Ahimsa Naturals IPO

1. The Primary Object to issue is Investment in Wholly Owned Subsidiary which is setting up a manufacturing unit ("Proposed Project"). Such Proposed Project is subject to the risk of unanticipated delays in implementation, cost overruns and certain Government approvals and licenses. If we are unable to implement the expansion plans at the planned cost or time or unable to obtain Government approvals and licenses, it could materially and adversely impact our business, results of operations and financial condition.

2. Our Statutory Auditors have included certain qualifications in the annexure to their audit reports, for half year ended September 30, 2024 and the years ended March 31, 2024, March 31, 2023 and March 31, 2022.

3. Our Company plans to invest an estimated sum of ?3,500 lakhs out of the Net proceeds of the Issue in our Wholly Owned Subsidiary namely "Shri Ahimsa Healthcare Private Limited" for setting up a manufacturing unit ("Proposed Project"). In the event of any delay in placing these orders, or if the vendors are not able to provide the equipment / machinery or complete the civil and related works etc. in a timely manner, or at all, may result in time and cost over-runs.

4. A significant majority of our revenues from operations are derived from a limited number of customers.

5. We are dependent on third parties for the supply of raw materials and such providers could fail to meet their obligations, which may have a material adverse effect on our business, results of operations and financial condition.

6. Some of the immediate relatives of our Promoters, who are deemed to be a part of the Promoter Group under SEBI ICDR Regulations have not provided consent and / or any confirmations, undertakings for them to be included as a members of the Promoter Group.

7. Our cost of production is exposed to fluctuations in the prices of raw material particularly Crude Caffeine and our Company has not entered into any agreement with respect to long-term supply for raw materials required.

8. Relevant documents of the Secretarial Records are not traceable by the Company.

9. Our Company has not complied with certain financial covenants of the financing facility and debt facility in past.

10. In the Past, one of our Independent Director, Mr. Rakesh Kumar, was involved in a legal investigation by the Directorate General of GST Intelligence (DGGI).

Objectives Shri Ahimsa Naturals IPO

1. Investment in our Wholly-Owned Subsidiary, Shri Ahimsa Healthcare Private Limited (SAHPL) for setting up a manufacturing unit at Sawarda, Jaipur, Rajasthan.

2. General Corporate Purposes.

Company Contact Details

Shri Ahimsa Naturals Limited
E-94, RIICO Industrial Area
Bagru, Ext.
Bagru
Phone: 0141-2202482
Email: info@shriahimsa.com
Website: https://www.naturalcaffeine.co.in/

Registrar Contact Details

Name: Cameo Corporate Services Limited
Phone: +91-44-28460390

Lead Mangers

  1. Srujan Alpha Capital Advisors Llp

Market Maker

  1. Choice Equity Broking Private Limited

Comments